Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

NCT05219734 is registered in ClinicalTrials.gov with Invitae Corporation as lead sponsor.

NCT NCT05219734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05219734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Lead sponsor
Invitae Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
November 29, 2021
Completion date
December 31, 2026
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, cancer, colorectal cancer, non small cell lung cancer, solid tumor